Lupin launches inhalation device in US

19 Feb 2015 Evaluate

Lupin has unveiled an inhalation-drug delivery device InspiraChamber in licensing pact with New Jersey-based respiratory research and development company InspiRX Inc. Developed by InspiRX, the InspiraChamber anti-static valved holding chamber is a device that has been designed to enhance delivery of aerosol therapies. The agreement grants Lupin exclusive rights to promote, distribute and market InspiraChamber in the US.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally.

 

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×